It affects the metabolic processes of the body, involving many organs that either from a profound or an absolute deficiency of insulin, are related to autoimmune destruction of insulin producing pancreatic beta cells (type 1, insulin dependent diabetes mellitus/juvenile) and from resistance to cellular metabolic effects, related to obesity (type 2 or non-insuline dependent diabetes mellitus) (see Tables 1 and 2).
It has been known for many years that the inclusion of vasoconstrictors in dental local anesthetic solution offers indisputable advantages.
Adrenaline or other catecholamines are used as vasoconstrictors in dental local anesthesia to increase their efficiency by promoting longer lasting anesthesia, reduce the toxic effects by slow absorption due to the vasoconstrictor effect and make the surgical area less bloody.
Few studies have been undertaken to show that plasma levels of glucose have been reported to be affected following administration of dental local anesthetic 2% Xylocaine containing adrenaline (1:80,000), The changes in blood sugar level following administration of adrenaline containing local anesthesia have been observed as a subject of controversy in some studies.
Aim is to compare the glycemic level among patients before, and after local anesthesia containing adrenaline 1:80,000 among patients who need dental extraction.
